ArticleACS omega2025
Partitioning Indicator Displacement Assay.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Indicator displacement assays work by detecting the replacement of an indicator from a binding site by an analyte. The binding sites are typically located on individual receptor molecules capable of carrying out molecular recognition. Here, we describe a new transduction mechanism based on analyte partitioning in a two-phase system, which we refer to as a partitioning indicator displacement assay (PIDA). In this assay, an indicator that is partitioned into the organic phase along with organic solutes is displaced by an analyte introduced into the aqueous phase. The indicator concentration in the receptor phase can be monitored optically, leading to the label-free detection of analytes. A sensor using cetyltrimethylammonium bromide (CTAB), octanol, and Blue 1 as the receptor phase was found to be selective for the small molecule Red 40 when compared to other similarly charged analytes. Fits to the sensorgrams reveal a quantitative trend consistent with a self-organized liquid crystalline layer whose thickness corresponds to organic solute concentrations. Coarse-grained molecular dynamics simulations provide insights into the mechanism behind the supramolecular aggregation that occurs at the interface, leading to the selectivity of the assay. The idea that a fluid organic phase could be selective in this way, depending on additives, provides a new way of thinking about biomolecular recognition in terms of small-molecule-dependent partitioning. The assay described here has potential for the detection of a range of small molecules and has implications for biological signaling in phase-separated systems.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.